Rockwell Medical (RMTI) Enterprise Value (2010 - 2026)

Rockwell Medical has reported Enterprise Value for 17 years, with the latest figure at -$23.9 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value fell 37.85% year-over-year to -$23.9 million; the trailing twelve-month figure through Mar 2026 stood at -$23.9 million (down 37.85% YoY), and the FY2025 full-year result was -$25.0 million, down 15.72% from the prior year.
• Enterprise Value for Q1 2026 stood at -$23.9 million, up from -$25.0 million in the prior quarter.
• The five-year high for Enterprise Value was -$8.6 million in Q1 2024, with the low at -$30.8 million in Q2 2022.
• Historically, Enterprise Value has averaged -$18.4 million across 5 years, with a median of -$18.3 million in 2024.
• Annual changes were most pronounced in 2022 — Enterprise Value jumped 78.54% — and 2025, when it slumped 101.08%.
• Rockwell Medical's Enterprise Value stood at -$21.5 million in 2022, then jumped by 49.12% to -$10.9 million in 2023, then slumped by 97.55% to -$21.6 million in 2024, then dropped by 15.72% to -$25.0 million in 2025, then increased by 4.43% to -$23.9 million in 2026.
• The last three Enterprise Value figures came in at -$23.9 million (Q1 2026), -$25.0 million (Q4 2025), and -$23.7 million (Q3 2025), per Business Quant data.